Our
Team
The Clinical Proteomics Platform consists of a dynamic team ready to listen to your questions.
Each member of the laboratory brings his or her own talents and knowledge to make the PPC the best choice for all your projects.
Christophe HIRTZ
Head of the Clinical Proteomics Platform of Montpellier
Full Professor in Clinical Proteomics and Biochemistry, Christophe Hirtz is specialized in clinical assays and R&D activities in the field of clinical proteomics since 1998 and neurodegenerative diseases since 2010.
Sylvain LEHMANN
Head of the laboratory of Biochemistry and Clinical Proteomics
Prof. Sylvain Lehmann M.D., Ph.D. is professor of Biochemistry at the Medical School of Montpellier. His clinical unit at the University Hospital Center (CHU) is in charge of the biological diagnosis of neurodegenerative disorders and he recently set up a reference Neurological biobank.
Jérôme VIALARET
MASS SPECTROMETRY Specialist - engineer
Laurent TIERS
ImmunoAssay specialist - engineer
“Hello, I am in charge of immunoassays in the laboratory on the latest technologies, SIMOA and MSD.”
Nelly GINESTET
laboratory technician
“I perform biological diagnostic assays for neurodegenerative disorders. I also manage samples for our biobank. Furthermore, I’m involved in research projects on new technologies such as SiMoA, MSD and ELLA.”
Aurore ATTINA
MASS SPECTROMETRY ENGINEER - SMART PROJECT MANAGER
“Hello everyone, I’m a mass spectrometry engineer and I joined PPC as the SMART project manager. My role is the development and implementation of methods for the detection and quantification of RNA changes.”
Laura FICHTER
Mass spectrometry engineer
“Engineer in mass spectrometry and proteomics, I am in charge of the research project on the TAU protein in multiple neurodegenerative pathologies.”
Jana KINDERMANS
engineer assistant - plasma boost project manager
“Hello! My name is Jana, I’m 21 years old and I’m from Belgium. I’m responsible for the Plasma Boost project: the detection of amyloid peptides in the blood on a MALDI-TOF (concerning Alzheimer’s disease).”
Marie-Laure PONS
PhD student from 2019 to 2022
“I’m a PhD student working on the development of innovative method in mass spectrometry for the discovery of biomarkers in the context of neurodegenerative diseases.”
Amandine AMALRIC
PHD STUDENT
“PhD student working on RNA epigenetic : our goals are to investigate the role of mRNA methylation in colorectal cancer progression and to identify potential RNA modification-based biomarkers in cancer and neurodegenerative diseases using mass spectrometry.”
Lisa MORICHON
Biology Engineer - SIMOA Manager
“”Involved in several research projects on neurodegenerative pathologies, I am developing ultrasensitive assays, mainly with the Single Molecule Array (SIMOA)”.”
Clinical Proteomics Platform
Institute for Regenerative Medicine & Biotherapy (IRMB)
Hôpital Saint Eloi
80 rue Augustin Fliche
34295 MONTPELLIER – Cedex 5
FRANCE